Examkin

Question

Difficulty: HardOrdering Imaging Studies

A 68-year-old man presents to the clinic complaining of generalized pruritus, dark urine, and pale stools for the past two weeks. He also reports an unintentional 6 kg (13 lb) weight loss over the last two months. He has no significant past medical history and takes no medications. Vital signs are within normal limits. Physical examination reveals scleral icterus and a palpable, non-tender mass in the right upper quadrant of the abdomen. Laboratory evaluation shows a total bilirubin of 14.2 mg/dL, direct bilirubin of 11.5 mg/dL, alkaline phosphatase of 650 U/L, aspartate aminotransferase (AST) of 85 U/L, and alanine aminotransferase (ALT) of 92 U/L.

Arrange the following imaging and procedural modalities in the most appropriate, evidence-based sequential order for the diagnostic workup and management of this patient, starting with the FIRST step.

  1. 1Transabdominal right upper quadrant ultrasound
  2. 2Multiphasic contrast-enhanced CT of the abdomen (pancreatic protocol)
  3. 3Endoscopic ultrasound (EUS) with fine-needle aspiration (FNA)
  4. 4Endoscopic retrograde cholangiopancreatography (ERCP) with biliary stenting

Answer

The correct sequence is: Transabdominal ultrasound, followed by Multiphasic CT of the abdomen, then Endoscopic ultrasound with FNA, and finally ERCP with biliary stenting.
The evaluation of painless jaundice begins with an ultrasound to confirm biliary dilation and exclude gallstones. Once malignant obstruction is suspected, a multiphasic CT (pancreatic protocol) is mandatory for staging and assessing resectability. Crucially, this CT must be performed before any biliary intervention. Following CT, EUS with FNA provides the necessary tissue diagnosis. Finally, ERCP with stenting is performed for therapeutic biliary decompression, effectively sequenced last to avoid introducing artifacts that would ruin the staging CT.

Step-by-Step Solution

1
Identify the clinical syndrome.
The patient has painless jaundice, weight loss, and a palpable gallbladder (Courvoisier sign), highly suspicious for a malignant biliary obstruction (e.g., pancreatic head adenocarcinoma or cholangiocarcinoma).
Recognizing the classic presentation guides the selection of the diagnostic algorithm.
2
Determine the initial imaging modality.
Select transabdominal right upper quadrant ultrasound.
Ultrasound is the standard, cost-effective first step to confirm biliary dilation and rule out simple gallstone disease in any patient with conjugated hyperbilirubinemia.
3
Select the modality for tumor staging and resectability assessment.
Select multiphasic contrast-enhanced CT (pancreatic protocol).
A high-quality CT is required to define the anatomy, identify the tumor mass, and assess vascular involvement (SMA, SMV, portal vein) to determine if the patient is a candidate for surgical resection.
4
Determine the modality for tissue acquisition.
Select Endoscopic Ultrasound (EUS) with Fine-Needle Aspiration (FNA).
Once the mass is staged radiographically, tissue diagnosis is required before starting neoadjuvant chemotherapy or proceeding with complex surgery, especially if the mass is borderline resectable or unresectable.
5
Sequence the therapeutic biliary decompression.
Place ERCP with stenting as the final step.
Biliary stenting should only be performed AFTER the staging CT scan, as stents cause artifact that obscures vascular margins and hinders accurate assessment of surgical resectability.

Key Concept

Diagnostic sequencing for suspected malignant biliary obstruction prioritizes non-invasive imaging (Ultrasound) for initial confirmation, followed by cross-sectional imaging (CT) for staging, BEFORE tissue acquisition (EUS-FNA) and therapeutic intervention (ERCP).
Rate this question

Topics

Ordering Imaging Studies

More questions from this topic